Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 060630/0088 | |
| Pages: | 5 |
| | Recorded: | 07/26/2022 | | |
| Attorney Dkt #: | A-2471-US02-PCT |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17769251
|
Filing Dt:
|
04/14/2022
|
|
Publication #:
|
|
Pub Dt:
|
05/02/2024
| | | | |
|
Title:
|
COMBINATION THERAPY OF KRAS INHIBITOR AND SHP2 INHIBITOR FOR TREATMENT OF CANCERS
|
|
|
Assignee
|
|
|
|
|
| ONE AMGEN CENTER DRIVE |
| THOUSAND OAKS, CALIFORNIA 91320-1799 |
|
|
Correspondence name and address
|
| |
AMGEN INC.
|
| |
ONE AMGEN CENTER DRIVE
|
| |
THOUSAND OAKS, CA 91320-1799
|
Search Results as of:
05/31/2024 09:48 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
